Table 2. Patients characteristics.
| Patient nr. | #1 | #2 | #3 | #4 | #5 | #6 | #7 | #8 | #9 | #10 |
|---|---|---|---|---|---|---|---|---|---|---|
| Age | 51 | 43 | 70 | 68 | 65 | 43 | 43 | 28 | 51 | 42 |
| SBP/DBP mmHg | 134/84 | 140/90 | 138/88 | 135/85 | 145/92 | 130/85 | 140/89 | 150/89 | 130/90 | 154/92 |
| Heart Rate bpm | 80 | 83 | 78 | 75 | 88 | 79 | 81 | 92 | 85 | 94 |
| BMI | 24.9 | 21.4 | 21.7 | 21.3 | 21.5 | 24.3 | 24.5 | 23.7 | 24.8 | 23.5 |
| Glycemia mmol/L | 5.22 | 4.99 | 3.99 | 4.20 | 3.98 | 5.35 | 5.12 | 4.89 | 5.55 | 4.77 |
| HbA1C mmol/L | 40.1 | 35.7 | 32.5 | 37.6 | 27.9 | 39.2 | 41.5 | 37.2 | 41.3 | 35.1 |
| Total Cholesterol mmol/L | 4.75 | 4.51 | 5.06 | 4.99 | 4.69 | 4.89 | 5.12 | 4.56 | 5.18 | 5.15 |
| HDL mmol/L | 1.22 | 1.62 | 1.35 | 1.10 | 1.25 | 1.13 | 1.04 | 1.11 | 1.02 | 1.03 |
| LDL mmol/L | 2.88 | 2.79 | 3.34 | 2.37 | 2.56 | 2.98 | 3.20 | 3.09 | 3.35 | 3.29 |
| Triglycerides mmol/L | 1.59 | 1.23 | 1.42 | 1.35 | 1.28 | 1.32 | 1.55 | 1.48 | 1.69 | 1.58 |
| GFR mL/min/1.73m2 | 87 | 87 | 85 | 90 | 83 | 89 | haemodialysis | 86 | 72 | 85 |
|
ERT therapy Algasidase- |
-alpha 0.2 mg/Kg | - alpha 0.2 mg/Kg | -beta 1 mg/Kg |
-beta 1 mg/Kg | - alpha 0.2 mg/Kg |
-beta 1 mg/Kg | -beta 1 mg/Kg |
- alpha 0.2 mg/Kg | - alpha 0.2 mg/Kg |
-beta 1 mg/Kg |
| Additional Treatment | EPO 10,000UI/week; Vitamin D; calcium; amlodipine 10mg doxazosin 2mg |
renal transplanted; amlodipine 10mg; doxazosin 2mg |
amlodipine 10mg; ramipril 5mg |
Ten healthy subjects (four males and six females, 29–50 years old) were recruited from the staff of the Department of Medicine-DIMED, at the University of Padova and used as control.